{"context":{"query":">>hgnc>>gwas","source_dataset":"hgnc","target_dataset":"gwas"},"stats":{"queried":1,"total":34,"mapped":1},"pagination":{"has_next":false},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"HGNC:6081","source":"HGNC:6081|insulin","targets":["GCST000038_11|Type 1 diabetes|IGF2, INS-IGF2, IGF2-AS|11|2.000000e-07","GCST000054_1|Type 1 diabetes|INS-IGF2, IGF2|11|4.000000e-09","GCST000392_32|Type 1 diabetes|MIR4686 - ASCL2|11|4.000000e-48","GCST000488_11|Prostate cancer|MIR4686 - ASCL2|11|3.000000e-33","GCST001191_21|Type 1 diabetes|INS-IGF2, INS|11|5.000000e-196","GCST001370_15|Prostate cancer (SNP x SNP interaction)|TNRC6B x MIR4686 - ASCL2|22 x 11|4.000000e-06","GCST001370_23|Prostate cancer (SNP x SNP interaction)|ANXA13 x MIR4686 - ASCL2|8 x 11|4.000000e-06","GCST001370_47|Prostate cancer (SNP x SNP interaction)|ACOXL, MIR4435-2HG x MIR4686 - ASCL2|2 x 11|4.000000e-06","GCST001370_48|Prostate cancer (SNP x SNP interaction)|TNRC6B x MIR4686 - ASCL2|22 x 11|3.000000e-06","GCST002112_1|Celiac disease|H19 - IGF2|11|7.000000e-06","GCST003097_23|Pediatric autoimmune diseases|INS-IGF2, IGF2, IGF2-AS|11|8.000000e-11","GCST005146_57|Birth weight|H19 - IGF2|11|7.000000e-10","GCST005536_19|Type 1 diabetes|INS-IGF2, INS|11|1.000000e-100","GCST005536_20|Type 1 diabetes|MIR4686 - ASCL2|11|6.000000e-10","GCST006196_1|Type 1 diabetes in high risk HLA genotype individuals (time to event)|INS - TH|11|3.000000e-07","GCST006197_5|Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)|INS - TH|11|1.000000e-07","GCST006197_8|Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)|INS - TH|11|6.000000e-06","GCST007246_2|Latent autoimmune diabetes vs. type 2 diabetes|INS-IGF2, INS|11|1.000000e-18","GCST007847_73|Type 2 diabetes|MIR4686 - ASCL2|11|3.000000e-13","GCST008114_9|Type 2 diabetes|MIR4686 - ASCL2|11|2.000000e-07","GCST008377_1|Type 1 diabetes|INS-IGF2, INS|11|1.000000e-06","GCST008464_3|Type 2 diabetes|TH|11|2.000000e-08","GCST009379_222|Type 2 diabetes|FAM99B, LINC02708|11|2.000000e-06","GCST009379_223|Type 2 diabetes|H19 - IGF2|11|2.000000e-08","GCST009379_224|Type 2 diabetes|IGF2|11|4.000000e-08","GCST009379_225|Type 2 diabetes|INS - TH|11|1.000000e-06","GCST009379_226|Type 2 diabetes|MIR4686 - ASCL2|11|4.000000e-26","GCST009916_5|Type 1 diabetes|INS - TH|11|1.000000e-13","GCST010118_38|Type 2 diabetes|MIR4686 - ASCL2|11|1.000000e-16","GCST010681_1|Type 1 diabetes|INS-IGF2, INS|11|1.000000e-160","GCST90000529_2|Type 1 diabetes|MIR4686 - ASCL2|11|2.000000e-31","GCST90000529_4|Type 1 diabetes|IGF2, INS-IGF2, IGF2-AS|11|1.000000e-09","GCST90000529_5|Type 1 diabetes|H19 - IGF2|11|1.000000e-09","GCST90026412_9|Severe autoimmune type 2 diabetes|INS-IGF2, INS|11|3.000000e-07"]}]}